4/A

PRIMARY DOCUMENT

Company: Inhibitor Therapeutics, Inc.
Filed: March 22, 2005
Period of Report: March 31, 2004
Accession Number: 0001234066-05-000015

View Document ↗ View on SEC.gov ↗